Kainos Laboratories

Kainos Laboratories EBIT

Delisted

The EBIT of Kainos Laboratories (4556.T) as of Oct 29, 2026 is 823.60 M JPY. In the previous year, EBIT was 865.21 M JPY — a change of -4.81% (lower).

EBIT

823.60 MJPY

YoY

-4.81%

Last updated:

In 2025, Kainos Laboratories's EBIT was 823.60 M JPY, a -4.81% increase from the 865.21 M JPY EBIT recorded in the previous year.

The Kainos Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
456.37 M JPY
Jan 1, 2019
581.24 M JPY
Jan 1, 2020
608.81 M JPY
Jan 1, 2021
632.30 M JPY
Jan 1, 2022
747.71 M JPY
Jan 1, 2023
821.09 M JPY
Jan 1, 2024
865.21 M JPY
Jan 1, 2025
823.60 M JPY
The Kainos Laboratories EBIT history
YEAREBITYoY
823.60 MJPY-4.81%
865.21 MJPY+5.37%
821.09 MJPY+9.81%
747.71 MJPY+18.25%
632.30 MJPY+3.86%
608.81 MJPY+4.74%
581.24 MJPY+27.36%
456.37 MJPY-3.88%
474.82 MJPY+7.33%
442.39 MJPY+10.21%
401.42 MJPY+26.11%
318.30 MJPY+27.52%
249.60 MJPY+14.97%
217.10 MJPY-3.77%
225.60 MJPY+8.15%
208.60 MJPY+741.13%
24.80 MJPY-53.56%
53.40 MJPY-39.04%
87.60 MJPY-44.27%
157.20 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kainos Laboratories Revenue

Kainos Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
4.39 B JPY
456.37 M JPY
277.93 M JPY
Jan 1, 2019
4.67 B JPY
581.24 M JPY
385.96 M JPY
Jan 1, 2020
4.61 B JPY
608.81 M JPY
398.57 M JPY
Jan 1, 2021
4.26 B JPY
632.30 M JPY
417.41 M JPY
Jan 1, 2022
4.61 B JPY
747.71 M JPY
512.33 M JPY
Jan 1, 2023
4.92 B JPY
821.09 M JPY
568.17 M JPY
Jan 1, 2024
5.06 B JPY
865.21 M JPY
637.97 M JPY
Jan 1, 2025
5.31 B JPY
823.60 M JPY
641.02 M JPY

Kainos Laboratories Margins

Kainos Laboratories stock margins

The Kainos Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kainos Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kainos Laboratories.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
45.88 %
10.40 %
6.34 %
Jan 1, 2019
48.56 %
12.44 %
8.26 %
Jan 1, 2020
51.62 %
13.21 %
8.65 %
Jan 1, 2021
54.28 %
14.85 %
9.80 %
Jan 1, 2022
52.17 %
16.20 %
11.10 %
Jan 1, 2023
51.05 %
16.68 %
11.54 %
Jan 1, 2024
50.46 %
17.11 %
12.62 %
Jan 1, 2025
50.41 %
15.52 %
12.08 %

Kainos Laboratories Stock analysis

What does Kainos Laboratories do? Kainos Laboratories Inc develops and manufactures pharmaceuticals, diagnostic reagents, and related chemical products for distribution and import/export. The company sells its products to healthcare providers, hospitals, and medical institutions within Japan and internationally. Its core offerings include prescription medications, diagnostic tools, and chemical compounds used in medical research and treatment. The business model relies on direct sales to medical facilities and global trade of its pharmaceutical and diagnostic solutions. Kainos Laboratories Inc focuses on the Japanese market with its headquarters in Bunkyo-Ku, Tokyo-To, while also engaging in international import/export activities. The company's revenue streams come from the sale of pharmaceuticals, diagnostic reagents, and chemical products to healthcare professionals and institutions. Its product portfolio targets medical practitioners and research organizations requiring specialized diagnostic and therapeutic solutions. The company operates with 144 full-time employees dedicated to the development, manufacturing, and distribution of its products. Kainos Laboratories Inc generates income through the commercialization of its pharmaceuticals and diagnostic reagents, serving both domestic and global clients in the healthcare sector. Sales are driven by demand for medical treatments and diagnostic tools in clinical and research settings. Kainos Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Kainos Laboratories's EBIT

Kainos Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Kainos Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Kainos Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Kainos Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Kainos Laboratories stock

EBIT of Kainos Laboratories is 823.60 M JPY in 2025.

EBIT of Kainos Laboratories changed from 865.21 M JPY to 823.60 M JPY, representing a -4.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Kainos Laboratories since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Kainos Laboratories historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Kainos Laboratories

All Key Metrics — Kainos Laboratories